DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
Public Review of CureSCi Common Data Elements
The Cure Sickle Cell Initiative (CureSCi) Standard Forms/Common Data Elements (CDEs) working groups have released draft standard forms and CDEs (Pre-Release of Version 1.0) for public review. The working groups are in the process of finalizing these documents and strongly encourage input during this public review period.
The goals are to support the National Institutes of Health (NIH) data-sharing roadmap and to address challenges of varied data collection standards and difficulties in comparing data between studies. CDEs are recommended by the NIH Strategic Plan for Data Science to improve data quality, facilitate collection of data, data-sharing and comparison and reduce study start-up time and overall study cost.
Related Content
-
education & researchSickle Cell PainSickle Cell Pain is a panoramic, in-dept...
-
news & eventsSCDAA And MedicAlert Pilot Program ApplicationSCDAA and MedicAlert Pilot Program Impr...
-
education & researchClinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a p...Children with sickle cell disease (SCD) ...
-
news & eventsSCD Patients Receiving Hydroxyurea in the U.S. Still Face Many ChallengesPeople with sickle cell disease (SCD) tr...
-
Community CenterMy Story: “Any Day Without Pain Is a Good Day!”At 32 years young, Shakir Cannon is not ...
-
Community CenterLiving With Sickle Cell Disease: One Person’s Story of Pain and Prejudice and Their Hopes for a Stem Cell TherapyMy name is Marissa Cors, I have sickle c...
-
news & eventsL-glutamine Oral Powder Significantly Reduces Acute Complications of Sickle Cell DiseaseApproved by the US Food and Drug...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.